KN  ....  It goes beyond 2022 and 2023.

"As at December 31, 2020, we had $0.1 million of cash. We need to raise additional capital to fund research, development and corporate activities over the next year or we may be forced to cease operations. As at December 31, 2020, we were committed to pay $6.9 million of trade and other payables, $1.1 million for research and development over the next twelve months, and $0.6 million of lease liabilities over the next twelve months."

and 

"As at December 31, 2021, we had $6 thousand of cash. We need to raise additional capital to fund research, development and corporate activities over the next year or we may be forced to cease operations. As at December 31, 2021, we were committed to pay $8.7 million of current trade and other payables, $1.6 million for research and development over the next twelve months, and $0.7 million of lease liabilities over the next twelve months. Furthermore, our $6.0 million secured convertible debenture with Hepalink is due on May 13, 2022. In addition, expenditures over the next twelve months under cancellable agreements with a contract research organization that is conducting our Phase 2 COVID-19 trial were estimated to total approximately $2.1 million. As at December 31, 2021, the Group is party to a commercialization partnership where corresponding estimated pre-commercialization activities over the next twelve months total approximately between $8.6 million and $12.2 million."

We've been cash-strapped since BETonMACE's primary endpoint did not reach statistical significance in late 2019.

The bottom line, RVX is still alive.

Koo